# The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers

> **NCT03342456** · PHASE4 · COMPLETED · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 184 (actual)

## Conditions studied

- Duodenal Ulcer Due to Helicobacter Pylori

## Interventions

- **DRUG:** Doxycycline Hyclate Enteric-Coated Capsules
- **DRUG:** Amoxicillin Capsules
- **DRUG:** Ilaprazole Enteric-Coated Tablets
- **DRUG:** Furazolidone Tablets
- **DRUG:** Potassium Citrate Tablets

## Key facts

- **NCT ID:** NCT03342456
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-13
- **Primary completion:** 2019-06-20
- **Final completion:** 2019-09-20
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03342456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03342456, "The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03342456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*